Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TRAMADOL HCL 25 MG TABLET

Tramadol Hydrochloride
$3.2606per EA
DEA Schedule CIV

Strength

25 mg/1

Manufacturer

Advagen Pharma Ltd.

NDC

72888016230

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TRAMADOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208708

On Market Since

11/28/2023

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price History

1W

0.0%

1M

-1.9%

3M

-3.6%

6M

+0.3%

1Y

+4.6%

3Y

N/A

5Y

N/A

All

+30.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

GS ANTI-DIARRHEAL 1 MG/7.5 ML
Generic
00113164526•L. Perrigo Company
$0.0268
per ML
LOPERAMIDE 1 MG/7.5 ML SOLN
Generic
00904683620•Major Pharmaceuticals
$0.0268
per ML
LOPERAMIDE 1 MG/7.5 ML SOLN
Generic
46122054426•AmerisourceBergen
$0.0268
per ML
ANTI-DIARRHEAL 1 MG/7.5 ML SOL
Generic
70000041701•Cardinal Health
$0.0268
per ML
ANTI-DIARRHEAL 1 MG/7.5 ML SOL
Generic
70000041801•Cardinal Health
$0.0268
per ML
FT ANTI-DIARRHEAL 1 MG/7.5 ML
Generic
70677110701•Strategic Sourcing Services LLC
$0.0268
per ML
GUAIFEN-CODEINE 100-10 MG/5 ML
Generic
00121077516•PAI Holdings LLC
$0.0324
per ML
CODEINE-GUAIFEN 10-100 MG/5 ML
Generic
58657050016•Method Pharmaceuticals LLC
$0.0324
per ML
CODEINE-GUAIFEN 10-100 MG/5 ML
Generic
69367027216•Westminster Pharmaceuticals LLC
$0.0324
per ML
MORPHINE SULF 10 MG/5 ML SOLN
Generic
00054023763•Hikma Pharmaceuticals USA Inc.
$0.0443
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy